OSR Health OSRHW
NASDAQ OSRHW
$0.05 +0.01 (+40.73%)
As of: Aug 24, 2026 · 3:58 PM EDT

OSR Health (OSRHW) Return on Assets (2023 - 2026)

OSR Health (OSRHW) posted Return on Assets of 0.0% for Q1 2026, up 28.24% sequentially from 0.0% in Q4 2025, and little changed YoY from 0.0% in Q1 2025.

OSR Health (OSRHW) Return on Assets (2023 - 2026) Analysis & Trends

OSR Health has reported Return on Assets for 4 years, with the latest figure at 0.0% in Q1 2026.

  • Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Assets rose to 0.0% in Q1 2026 per OSRHW's latest filing, from 0.0% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q4 2023 and troughed at 0.0% in Q3 2024.
  • A 4-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
  • The widest YoY moves for Return on Assets: up 0 bps in 2024, down 0 bps in 2024.
  • Over 4 years, Return on Assets stood at 0.0% in 2023, then tumbled by 1518 bps to 0.0% in 2024, then tumbled by 47 bps to 0.0% in 2025, then increased by 28 bps to 0.0% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Vertex Pharmaceuticals 138.97 Bn 131.12 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 85.15 Bn 77.15 Bn 3.93 Bn 0.00%
3 Argenx Se 62.84 Bn 57.65 Bn 1.37 Bn -
4 Moderna 55.74 Bn 50.60 Bn 52.00 Mn 0.00%
5 BeOne Medicines 41.53 Bn 36.43 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.60 Bn 28.29 Bn 992.69 Mn 0.00%
7 BioNTech SE 27.32 Bn 8.93 Bn 668.28 Mn 0.00%
8 Royalty Pharma 27.29 Bn 26.45 Bn - 0.00%
9 Insmed 26.99 Bn 25.83 Bn 358.27 Mn 0.00%
10 OSR Health 1.40 Mn 20.39 Mn 86,605.00 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%